In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.

Memorial Sloan Kettering Cancer Center using NVision’s quantum-based MRI technology to advance research for more rapid cancer ...

Francis Medical has received FDA clearance for its Vanquish water vapor ablation system for the management of prostate cancer ...

The newly offered, targeted ozone injections are a minimally invasive therapy with potential benefits for prostate tissue and function GREENVILLE, SC / ACCESS Newswire / December 9, 2025 / The ...

BioNTech stock is a "Strong Buy", driven by positive phase 3 data for gotistobart in 2nd-line squamous NSCLC patients. Read ...

NVision Polaris hyperpolarization technology to be utilized in preclinical research for more rapid and precise cancer diagnosis and treatment monitoring NVision Imaging Technologies (NVision), develop ...

As new technology capable of detecting dozens of early-stage cancer types with a single blood test hits the market, support ...

An OU Health cancer center is set to open in McAlester on Dec. 15, 2025, restoring southeast Oklahoma's access to expanded ...

Learn about prostate cancer symptoms, diagnosis, staging and the latest treatments including robotic surgery, SBRT, radioligand therapy and targeted drugs.

Stereotactic body radiotherapy delays the need for long-term androgen deprivation therapy (ADT) in many men with oligometastatic prostate cancer, a study shows.

PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.